B Group, Inc.

B Group, Inc. reported 19 holdings worth US$162M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

B Group, Inc. reported 19 holdings worth US$162M as of Sep 30, 2026. Largest: ADMA Biologics Inc, Sensei Biotherapeutics, Inc. and Palisade Bio, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
19
Value as reported
US$162M

The filing in full

CompanySharesValue as reported% of portfolio
ADMA Biologics Inc3.26MUS$32.7M20.2%
Sensei Biotherapeutics, Inc.610KUS$18.1M11.2%
Palisade Bio, Inc.11.4MUS$15.4M9.5%
NRX Pharmaceuticals, Inc.4.28MUS$12.5M7.7%
Zai Lab Ltd.451KUS$11.9M7.3%
Praxis Precision Medicines, Inc.33,237US$9.68M6.0%
Sight Sciences, Inc.970KUS$9.08M5.6%
Taysha Gene Therapies, Inc.1.8MUS$8.77M5.4%
Iovance Biotherapeutics, Inc.425KUS$6.3M3.9%
Structure Therapeutics, Inc.180KUS$5.63M3.5%
Spyre Therapeutics, Inc.62,500US$5.56M3.4%
Cellectis S.A.3.28MUS$4.96M3.1%
Aura Biosciences, Inc.764KUS$4.8M3.0%
Bright Minds Biosciences Inc.95,000US$4.73M2.9%
Oruka Therapeutics, Inc.55,000US$4.58M2.8%
Assembly Biosciences, Inc.176KUS$4.13M2.5%
Ultragenyx Pharmaceutical Inc.135KUS$2.03M1.3%
Foghorn Therapeutics Inc.200KUS$714K0.44%
Q32 Bio Inc.65,000US$538K0.33%

Source

Download original · View original at SEC

Related